This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Compounding Pharmacy Compliance Year-End Summit
December 9-10, 2025
The W PhiladelphiaPhiladelphia, PA

Victor Hill
Director of Quality at Vios Compounding
Speaker

Profile

Victor Hill is the Director of Quality at a 503A Compounding Pharmacy. With a background as a Biochemist, he applies a rigorous, science-based approach to compliance and formulation design.

Victor is a specialist in pharmaceutical quality systems, including adherence to USP General Chapters <795>, <797>, and <800>. He has driven the launch and ongoing quality control for the pharmacy’s GLP-1 offerings, including semaglutide and tirzepatide. His work includes overseeing API sourcing, Certificate of Analysis (CoA) reviews, and leading the R&D efforts that have resulted in formulation improvements for stability and efficacy.

In this session, Victor will detail best practices for the GLP-1 Compliance Workshop, guiding attendees through critical topics such as: establishing protocols for dosing accuracy, validating cold-chain shipping to protect drug potency, and utilizing quality systems to ensure product consistency and reduce compliance risk.

Agenda Sessions

  • GLP-1 Compliance Workshop Part 1: Clinical & Quality Protocols

    9:00am